Cargando…
Assessing Gene Expression Related to Cisplatin Resistance in Human Oral Squamous Cell Carcinoma Cell Lines
Cisplatin-based chemotherapy has been effectively used to treat oral cancer, but treatment often fails owing to the development of drug resistance. However, the important gene expression alterations associated with these resistances remain unclear. In this study, we aimed to identify the gene expres...
Autores principales: | Choi, Hyeong Sim, Kim, Young-Kyun, Yun, Pil-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228236/ https://www.ncbi.nlm.nih.gov/pubmed/35745623 http://dx.doi.org/10.3390/ph15060704 |
Ejemplares similares
-
Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines
por: Choi, Hyeong Sim, et al.
Publicado: (2019) -
Increased FOXM1 Expression by Cisplatin Inhibits Paclitaxel-Related Apoptosis in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma (OSCC) Cell Lines
por: Choi, Hyeong Sim, et al.
Publicado: (2020) -
Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis
por: Choi, Hyeong Sim, et al.
Publicado: (2021) -
The influence of p53 mutation status on the anti-cancer effect of cisplatin in oral squamous cell carcinoma cell lines
por: Jo, Deuk-Won, et al.
Publicado: (2016) -
Anticancer effects of CKD-602 (Camtobell(®)) via G2/M phase arrest in oral squamous cell carcinoma cell lines
por: KIM, YOUNG-KYUN, et al.
Publicado: (2015)